Masimo (NSDQ:MASI) said today it won FDA clearance for its RAS-45 acoustic respiration sensor as part of its Rainbow Acoustic Monitoring system, cleared for use with infants and neonatal patients. With the clearance, the Rainbow Acoustic Monitoring system is now cleared for use with patients of all sizes, the Irvine, Calif.-based company said. Previously, the system […]
Masimo touts study exploring ORi’s ability to detect oxygenation during moderate hyperoxia
Masimo (NSDQ:MASI) today released results from a study exploring the ability of the company’s Oxygen Reserve Index (ORi) to show trends in oxygenation during moderate hyperoxia. The company’s ORi measure is intended to serve as a non-invasive, relative indicator of an individual’s oxygen reserve during moderate hypoxia. The measurement can be trended and can be used […]
Study: Home baby pulse oximetry monitors may be inaccurate, unnecessary
Baby monitors designed to track physiological conditions may be inaccurate and cause parents more stress than necessary, according to a new report published in the Journal of the American Medical Association. Researchers at the Children’s Hospital of Philadelphia studied two such monitors, the Owlet Smart Sock2 and the Baby Vida, both of which are not […]
Masimo, Dominion bury the hatchet in blood monitoring IP infringement suit
Diagnostic tech developer Masimo (NSDQ:MASI) and rival Dominion have settled a suit over blood monitoring patents, according to recently released court documents. The two companies said they reached a settlement deal over a suit brought against Masimo by Dominion claiming it infringed on patents related to noninvasive blood monitoring technology. The agreement does not include payments […]
Masimo touts study exploring pulse oximetry pre-screening for OSA in children with down syndrome
Masimo (NSDQ:MASI) yesterday released results from a study exploring home pulse oximetry monitoring’s ability to serve as an initial screening method to determine which children with Down syndrome should be recommended to undergo sleep studies to diagnose obstructive sleep apnea. The Irvine, Calif.-based company said that children with Down syndrome are at high risk of obstructive […]
Masimo Q2 posts beat-and-raise Q2
Masimo (NSDQ:MASI) today posted second quarter earnings that beat expectations on Wall Street and raised its guidance for the remaining fiscal year. The Irvine, Calif.-based company posted profits of $43.8 million, or 79¢ per share, on sales of $211.6 million for the three months ended June 30, seeing the bottom line shrink 2.8% while sales grew […]
7 medtech stories we missed this week: July 13, 2018
From Angiodroid receiving CE Mark approval to Masimo launching its vital signs app, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Angiodroid wins CE Mark for Angiopulse IABP Angiodroid announced in a July 11 press release that it has received CE Mark approval for its AngioPulse intra-aortic balloon […]
7 medtech stories we missed this week: June 22, 2018
From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in […]
Masimo raises outlook on Street-beating Q1 numbers
Masimo (NSDQ:MASI) yesterday raised its outlook for the rest of the year after posting first-quarter results that beat both sales and earnings forecasts, despite lower profits. Irvine, Calif.-based Masimo reported profits of $45.6 million, or 82¢ per share, on sales of $213.0 million for the three months ended March 31, for a bottom-line slide of -11.5% […]
5 medtech stories we missed this week: April 20, 2018
From CHF Solutions’ new Italian distribution deal to Masimo’s CE Mark approval, here are five medtech stories we missed this week but thought were still worth mentioning. 1. CHF Solutions signs Italian distribution deal CHF Solutions announced in an April 17 press release that it has signed a new distribution agreement with TRX Italy to distribute […]
Masimo expected to grow through 2025 as it branches out, analyst says
Masimo (Nasdaq: MASI) should enjoy growth through the middle of the next decade, thanks to its exploration of opportunities outside its core market that are more driven by hospital automation, according to a new equity research report out of Barclays. Masimo is on track to having 8–10% top-line growth and 12–15% earnings per share growth through […]
- 1
- 2
- 3
- …
- 18
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+